Lumin Health Newsroom

A clinical-operator perspective on Spravato, psychedelic care, treatment-resistant depression, and the future of interventional psychiatry.

We respond to media inquiries within 24 hours.

Email media team →

In the news

Recent media coverage, AMAs, and selected peer-reviewed publications featuring Lumin Health clinicians.

Fierce Pharma · October 7, 2026

Scaling psychedelics comes with uncertainty ‘baked into the sauce’

Psychiatric Times · October 5, 2026

Esketamine in Treatment-Resistant Depression: Evidence, Safety, and Practice-Building (video series)

FOX 5 DC · WTTG · September 23, 2026

Health Watch: Dr. Ben Yudkoff, Co-Founder & Chief Medical Officer of Lumin Health, joins FOX 5 DC (video)

The American Bazaar · August 12, 2026

Harvard’s Aakash Sathappan named Lumin Health site director

citybiz · August 5, 2026

Lumin Health Names Dr. Aakash Sathappan Site Director for Brookline Clinic

Charity Journal · May 22, 2026

Lumin Health expands ketamine and Spravato depression treatment to the Washington, D.C. area

National Law Review · May 20, 2026

Lumin Health opens first location outside Massachusetts, bringing ketamine and FDA-approved Spravato to the D.C. area

CBS News Washington, DC · WUSA9 · May 19, 2026

New Bethesda clinic offers hope with ketamine treatments for depression

CBS News Boston · May 16, 2026

How Boston health clinics are using ketamine to help treat mental health: “It’s worth it.”

CBS News Boston · WBZ-TV · May 15, 2026

How ketamine is helping to treat patients who struggle with traditional mental health therapy (video)

PharmaVoice · March 2026

J&J's blockbuster Spravato is setting the stage for managing psychedelics' risks

Psychiatric Times · March 10, 2026

Beyond Monoamines: Ketamine and Interventional Psychiatry (video)

Reddit · r/TherapeuticKetamine · March 6, 2026

AMA on r/TherapeuticKetamine — Dr. Ben Yudkoff on ketamine therapy and Spravato

Psychiatric Times · March 5, 2026

Mechanisms of Ketamine: Insights from Ben Yudkoff, MD (video)

Reddit · r/Spravato · November 21, 2025

AMA: I'm Dr. Ben Yudkoff, Psychiatrist & Co-founder — community questions on Spravato, ketamine, and treatment-resistant depression

Selected publications

Peer-reviewed work co-authored by Lumin Health clinicians. Distinct from media placements.

Video & podcast appearances

Long-form interviews and on-camera appearances featuring Lumin Health clinicians.

More coverage coming. Lumin Health Co-Founder Dr. Benjamin Yudkoff is preparing op-eds on the in-network model for Spravato and the next wave of psychedelic medicine. Reporters: press@lumin.health.

Key facts about Lumin Health

A clinical-operator perspective for reporters covering Spravato, treatment-resistant depression, and psychedelic medicine.

Five-site in-network operator

Lumin Health operates five interventional psychiatry locations — Newton, Cambridge, Woburn, Brookline (MA) and Bethesda (MD) — fully in-network with Aetna, BCBS, Cigna, UnitedHealthcare, Optum, Medicare, and 8+ other major payers.

View locations →

Hundreds of patients each month

Across the network, Lumin Health treats hundreds of patients each month receiving Spravato (esketamine), IM ketamine, oral ketamine, and integrative psychotherapy for treatment-resistant depression and related conditions.

Patient experience →

Harvard-trained medical leadership

Four of five Lumin Health medical directors are Harvard Medical School faculty. Co-Founder and CMO Dr. Benjamin Yudkoff previously served as Medical Director of the Brigham and Women's Faulkner Hospital Interventional Psychiatry Service.

Meet the team →

On-the-record clinical experts

Five board-certified psychiatrists are available for media interviews on Spravato access, treatment-resistant depression, ketamine and esketamine clinical care, MDMA-assisted psychotherapy training, and the future of interventional psychiatry.

Email press team →

24-hour media response

We respond to all media inquiries within 24 hours. For breaking news on Spravato, FDA action on psychedelics, or J&J earnings coverage, our experts can respond within 2 hours during business hours.

Email media team →

Hundreds of 5-star patient reviews

Lumin Health patients consistently rate their treatment experience 5 stars across Google and review platforms. Many describe Lumin Health as the first place they felt heard after years of treatment-resistant depression.

Patient reviews →

Meet our medical leadership

Six psychiatrists across Lumin Health's locations, available for press interviews, expert quotes, and original-data exclusives.

Dr. Benjamin Yudkoff, MD, MA — Co-Founder & Chief Medical Officer, Lumin Health

Featured spokesperson

Benjamin Yudkoff, MD, MA

Co-Founder & Chief Medical Officer, Lumin Health

Instructor in Psychiatry · Harvard Medical School Board-certified psychiatrist
"Lumin Health is a clinical-operator voice on the in-network model that finally made Spravato accessible at scale. Our medical directors — Drs. Mosquera, Sathappan, Fletcher, Knable, and myself — are available for press interviews, expert quotes, and original-data exclusives."

Also available for press: Dr. Matthew Mosquera (Regional Medical Director, double board-certified general + addiction psychiatry), Dr. Aakash Sathappan (Brookline; authored first informed consent guidelines for ketamine in adolescent TRD), Dr. SJ Fletcher (Woburn; MAPS-trained MDMA-assisted psychotherapy), Dr. Michael Knable (Bethesda; former Chair of Psychiatry, Suburban Hospital, Johns Hopkins Medicine), and Dr. Samaneh Keshavarz (Bethesda; women’s mental health and reproductive psychiatry).

Areas of media expertise

Lumin Health spokespeople are available to comment on Spravato access, treatment-resistant depression, esketamine and ketamine clinical care, MDMA-assisted psychotherapy training, the FDA pathway for psychedelic medicine, insurance integration in psychiatry, and the mental-health workforce shortage.

Spravato access & insurance integration Treatment-resistant depression (TRD) Ketamine & esketamine clinical care MDMA-assisted psychotherapy Psilocybin & FDA pathway Adolescent psychiatric care Trauma-informed care & IFS Addiction psychiatry Mental health workforce shortage Treatment options in mental health for hard-to-beat cases
Email media team →

Five Lumin Health locations across MA and MD

A friendly face at the Lumin Health front desk, greeting patients as they enter for their bespoke insurance-covered ketamine treatment and esketamine therapy with 5-star reviews and Harvard-trained doctors and physicians
Newton
10 Langley Road, Suite 200
Newton, MA 02459
Phone 617-741-5931
Learn more
Cambridge (Harvard Square)
50 Church Street, 3rd floor
Cambridge, MA 02138
Phone 781-734-6854
Learn more
Woburn
300 TradeCenter Drive, Suite 3400
Woburn, MA 01801
Phone 617-644-4045
Learn more
Brookline
1101 Beacon Street, Suite 4E
Brookline, MA 02446
Phone 617-925-9852
Learn more
Bethesda
4825 Bethesda Ave Suite 200
Bethesda, MD 20814
Phone 301-783-0326
Learn more

Press contact

For all media inquiries — interview requests, quote requests, story development, and original-data exclusives — email press@lumin.health. We respond within 24 hours.

Media contact

Alec Sherman

Head of Digital, Lumin Health

Email: press@lumin.health

For breaking news, contact Alec Sherman directly.

Email press team →